Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Gross Margin: 2017-2025

Historic Gross Margin for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to 100.00%.

  • Arcus Biosciences' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Arcus Biosciences' latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Over the past 5 years, Arcus Biosciences' Gross Margin peaked at 100.00% during Q1 2021, and registered a low of 100.00% during Q1 2021.
  • Its 3-year average for Gross Margin is 100.00%, with a median of 100.00% in 2025.